What are the elimination half‑life and relative potency of diazepam (Valium) compared with lorazepam (Ativan) and alprazolam (Xanax)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 13, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Benzodiazepine Comparison: Half-Life and Potency

Valium (diazepam) has the longest half-life at 20-120 hours, Ativan (lorazepam) is intermediate at 8-15 hours, and Xanax (alprazolam) is shortest at approximately 11 hours; for potency, lorazepam is the most potent, followed by alprazolam, with diazepam being the least potent of the three.

Half-Life Comparison

Diazepam (Valium)

  • Elimination half-life: 20-120 hours 1
  • Terminal elimination phase can extend up to 48 hours for the parent compound 2
  • Active metabolite (N-desmethyldiazepam) half-life: up to 100 hours 2
  • In elderly patients, half-life increases by approximately 1 hour for each year of age, starting from 20 hours at age 20 2
  • The prolonged duration results from extensive tissue distribution and active metabolite accumulation, particularly in patients with renal dysfunction 1

Lorazepam (Ativan)

  • Elimination half-life: 8-15 hours 1
  • No active metabolites 1
  • Half-life increases in patients with renal failure 1
  • More predictable pharmacokinetics due to lack of active metabolites

Alprazolam (Xanax)

  • Mean elimination half-life: approximately 11.2 hours (range 6.3-26.9 hours) 3
  • In elderly patients: 16.3 hours 3
  • In obese patients: 21.8 hours 3
  • In hepatic impairment: 19.7 hours 3
  • Active metabolites (4-hydroxyalprazolam and α-hydroxyalprazolam) contribute minimally to clinical effects due to low concentrations (<4% of parent compound) 3

Potency Comparison

The relative potency hierarchy from the Critical Care Medicine guidelines is clear: lorazepam > midazolam > diazepam 1. While alprazolam is not directly compared in these ICU-focused guidelines, research data provides additional context:

  • Lorazepam is more potent than diazepam: The typical sedative dose equivalence is diazepam 10 mg = lorazepam 2-2.5 mg 4, indicating lorazepam is approximately 4-5 times more potent

  • Alprazolam vs. Diazepam: In anxiety treatment, optimal therapeutic doses averaged alprazolam 2 mg vs. diazepam 15.8 mg 5, suggesting alprazolam is approximately 8 times more potent than diazepam

  • Practical potency ranking: Lorazepam ≥ Alprazolam >> Diazepam

Clinical Implications

Duration of Action Paradox

Despite diazepam's much longer half-life, a single IV dose of diazepam has a shorter duration of clinical action than lorazepam 6. This occurs because diazepam is highly lipid-soluble with a volume of distribution 10 times larger than lorazepam (133 L/kg vs. 12 L/kg), causing rapid redistribution from the brain to peripheral tissues 6.

Key Clinical Considerations

For short-term use (1-2 days):

  • Lorazepam may have longer emergence time due to greater potency and slower clearance 1
  • Diazepam and alprazolam have faster onset (2-5 minutes and 1-2 hours respectively) 1

For prolonged use:

  • Diazepam shows the most accumulation due to active metabolites and extremely long half-life 1
  • Alprazolam's shorter half-life may lead to more severe withdrawal symptoms 7
  • Lorazepam has intermediate accumulation risk but carries propylene glycol toxicity risk at doses ≥1 mg/kg/day 1

In elderly patients:

  • Diazepam half-life can reach 86 hours (vs. 31 hours in young adults) 8
  • Alprazolam half-life increases to 16.3 hours 3
  • All benzodiazepines show significantly increased sensitivity in elderly patients 1

In hepatic impairment:

  • Diazepam half-life can exceed 500 hours in severe cirrhosis 2
  • Alprazolam half-life increases to 19.7 hours 3
  • Clearance decreases substantially for all three agents

Tapering Implications

The vastly different half-lives have critical implications for discontinuation. Hyperbolic (proportionate) tapering is superior to linear tapering 9, with final doses potentially needing to be as low as 0.2 mg diazepam equivalents to avoid withdrawal. Diazepam's long half-life may reduce acute withdrawal severity but delays recovery, while alprazolam's short half-life increases withdrawal severity and requires more careful tapering 7.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.